Get a glimpse into our company and investor data—powered by the PitchBook Platform
$13.80SHARE PRICE(As of Wednesday Closing)
Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and others.